Ask AI

MISSION POSSIBLE: Elevating Risk Recognition, Treatment Decisions, and Pancreatitis Prevention in Severe Hypertriglyceridemia

Improve your practice in identifying, assessing, and managing patients with severe hypertriglyceridemia (sHTG) through expert-written ClinicalThought commentaries, downloadable slides, an on-demand webcast, and an ACTiconsult. With a focus on risk assessment and patient-specific evaluation, learn how to integrate current and emerging triglyceride-lowering therapies to improve cardiovascular and acute pancreatitis risk in patients with sHTG.

Share

Program Content

Events

Activities

Acute Pancreatitis in Severe Hypertriglyceridemia
MISSION POSSIBLE: Are We Doing Enough to Prevent Acute Pancreatitis in Severe Hypertriglyceridemia?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.